Product Details

Verfluc Capsules meet British Pharmacopoeia (BP) standards for the treatment of bacterial infections. Specifically, each capsule delivers Flucloxacillin Sodium equivalent to 500mg Flucloxacillin. As a result, it offers targeted antibacterial coverage against penicillinase-producing staphylococcal strains.

The capsules contain:

• Flucloxacillin Sodium BP (equivalent to Flucloxacillin 500mg) – A penicillinase-resistant penicillin that inhibits bacterial cell wall synthesis. Consequently, it remains effective against Staphylococcus strains that produce beta-lactamase enzymes capable of inactivating standard penicillins.

Physicians prescribe Verfluc for the treatment of infections caused by penicillinase-producing staphylococci, including skin and soft tissue infections, bone and joint infections, and respiratory tract infections. In addition, its targeted spectrum makes it a reliable first-line choice when staphylococcal resistance is suspected or confirmed. Because of this profile, Verfluc suits general practice, surgical, and hospital settings managing resistant staphylococcal infections.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports easy, convenient dosing
• Furthermore, each capsule delivers precise, validated dosage accuracy at 500mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against moisture
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies